COVID-19 tijdens zwangerschap en borstvoeding: wat weten we al?
COVID-19 during pregnancy and lactation: what do we already know?
Nederlands Tijdschrift voor Geneeskunde , Volume 164
SARS-CoV-2 has rapidly spread worldwide since December 2019. Obviously, pregnant and lactating women will also be infected with SARS-CoV-2. Pregnant women, however, are a risk population for developing severe respiratory infections. Currently, the knowledge on potential risks and consequences of COVID-19 during pregnancy and lactation is limited. Available data show that pregnant women suffer from similar symptoms compared to non-pregnant patients. There is no evidence as yet that COVID-19 has a more serious course during pregnancy. Although pregnant women might suffer from a wide variety of symptoms, most of them are asymptomatic. Maternal SARS-CoV-2 infection might lead to adverse neonatal outcomes, such as prematurity or respiratory symptoms. There is currently no conclusive evidence of absence of intrauterine transmission of the virus; the virus has not been detected in breastmilk in most studies, although passage into breastmilk cannot be completely excluded.
|Nederlands Tijdschrift voor Geneeskunde|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Ceulemans, M. (M.), Cuppers, B. (B.), de Vries, L. (L.), Allegaert, K.M, Duvekot, J.J, & van Puijenbroek, E.P. (2021). COVID-19 tijdens zwangerschap en borstvoeding: wat weten we al?. Nederlands Tijdschrift voor Geneeskunde, 164. Retrieved from http://hdl.handle.net/1765/135198